Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to EC1997002038ApriorityCriticalpatent/ECSP972038A/en
Publication of ECSP972038ApublicationCriticalpatent/ECSP972038A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Fodder In General
(AREA)
Abstract
La presente invención se refiere al fomento del crecimiento y la eficacia del pienso en pollos sanos y, más particularmente a un método para aumentar el crecimiento y la eficacia del pienso en pollos sanos mediante el empleo de la frenolicina B y/o una sal o éster fisiológicamente aceptables de la misma como ingrediente (s) activo (s) para composiciones de pienso para pollos conteniendo frenolicina B y/o una sal o éster de la misma fisiológicamente aceptables como ingrediente (s) activo(s), y a un método de preparación de dichas composiciones de pienso para pollos.The present invention relates to promoting the growth and efficiency of feed in healthy chickens and, more particularly to a method of increasing the growth and efficiency of feed in healthy chickens by using frenolicin B and / or a salt or ester physiologically acceptable as active ingredient (s) for chicken feed compositions containing frenolicin B and / or a physiologically acceptable salt or ester thereof as active ingredient (s), and to a method of preparation of said chicken feed compositions.
Use of anabolic compositions for bone mass based on effective non-toxic amounts of Ä3- (n, n-dimethylamino) -1-hydroxypropylidene-bisphosphonic acid or the monosodium salt or other pharmaceutically acceptable salt thereof
ANHYDRA CRYSTALLINE FORM OF R (-) - N- (4,4-DI (3- METHYLENE-2-IL) BUT-3-ENIL) -NIPECOTIC ACID, A PHARMACEUTICAL COMPOSITION AND THE USE OF SUCH CRYSTALLINE SALT FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION